Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Autophagy

The Cellular Recycling Process Behind the Hype

Evidence grade 2 of 5, Thin. Read how the Atlas grades evidence.

0 human trials, about 5000 studies, Largely cell and animal models; limited human data. The written rationale for this grade is still being prepared.

FDA
Not a regulated intervention; a biological process
WADA
Not applicable

Reference only. Not medical advice.

What can go wrong

Autophagy itself is a normal, essential cellular process, not a risk. The risk here is interpretive and behavioral. Acting on specific autophagy unlocks at X hours claims, and fasting longer or harder to chase them, is not supported by reliable human evidence, and prolonged fasting carries its own physiological risks. Because autophagy is context dependent and its excess is associated with some disease processes, more is not simply better. Anyone considering extended fasting, especially people who are pregnant, underweight, diabetic, on glucose-lowering or other medications, or with a history of disordered eating, should work with a qualified healthcare provider rather than a duration target drawn from social media. This entry is educational and is not medical advice or a fasting protocol.

Autophagy, Greek for self-eating, is the cell's housekeeping system: it breaks down and recycles damaged proteins, organelles, and debris, and it ramps up under stress including nutrient deprivation. The basic biology is settled and Nobel-grade. Christian de Duve coined the term in 1963 after discovering the lysosome, and Yoshinori Ohsumi worked out the controlling genes in yeast in the 1990s, earning the 2016 Nobel Prize in Physiology or Medicine. Fasting reliably upregulates autophagy in animal models, which is the real kernel behind the fasting enthusiasm. The hype outruns the human evidence. The popular claim that autophagy switches on at 16 (or 24, or 72) hours of fasting is not established in people, where the process is genuinely hard to measure and the timing is uncertain. The best direct human signal so far is exploratory and modest. The honest split: the cell biology is high confidence, the hour-by-hour human fasting claim is low and largely indirect.

The cell's self-cleaning and recycling system, real, Nobel-winning science, and the single most overhyped word in fasting marketing.

What it is invoked to explain

Claims this idea is used to support. Whether it supports them is the rest of the entry.

  • Understanding the real cellular mechanism often invoked to explain fasting claims
  • Cellular quality control: clearing damaged proteins and organelles and supporting stress resistance
  • Context for longevity, neurodegeneration, immunity, and cancer research where autophagy is studied
  • Separating settled basic science from contested hour-by-hour human marketing claims

What people get wrong

  • Often saidAutophagy reliably switches on at 16 (or 24) hours of fasting in humans.

    ActuallyThis specific timing is not established in humans. The hour-thresholds come largely from animal and cell studies. Reviews and clinical references, including Cleveland Clinic, state that animal data suggest autophagy may begin somewhere around 24 to 48 hours and that there is not enough research on the ideal timing to trigger human autophagy. Autophagy behaves more like a dimmer than an on-off switch, and the human timing is genuinely uncertain.

  • Often saidMore autophagy is always better.

    ActuallyAutophagy is tightly regulated for good reason. Its role is context dependent: in cancer biology it can suppress early tumor formation but help established tumors survive stress, including chemotherapy. Both too little and too much autophagy are associated with disease, so framing more as uniformly good is a misreading of the science.

  • Often saidHuman studies have proven that fasting drives meaningful autophagy on a schedule.

    ActuallyDirect human evidence is limited and largely indirect. There are no completed RCTs with human autophagy as a primary endpoint reporting a clear positive result. The strongest direct signal (Bensalem 2025) is an exploratory post hoc analysis showing a modest 6-month between-group difference (P=0.04) with no significant rise within the fasting group, and a purpose-built time-course trial was withdrawn with zero enrollment.

  • Often saidOhsumi's Nobel Prize proves that fasting works for longevity in people.

    ActuallyOhsumi's prize was for working out how autophagy operates at the level of yeast genetics and cell biology, not for any human fasting or longevity outcome. His work is foundational basic science and is frequently misattributed in fasting marketing as a human-outcome endorsement.

Who profits, and who pushes back

  • Human-physiology and metabolism reviewers

    Pushes backClinical and metabolism researchers

    The autophagy-by-the-clock claims used to market fasting are not supported by reliable human data. Measuring autophagy in living people is genuinely difficult, and the best direct human signal so far is exploratory and modest.

  • Post-Ohsumi cell-biology consensus

    Pushes backAutophagy research field

    Autophagy is essential and tightly regulated. Because both deficiency and excess are linked to disease, and its role can flip between protective and harmful depending on context, framing more autophagy as uniformly good is a misreading.

  • Clinical trial record

    Pushes backClinicalTrials.gov registry

    A dedicated study of the time course of fasting-induced autophagy in humans was withdrawn because no participants could be enrolled, a concrete reminder of how hard this question is to answer directly in people.

  • Dr. Yoshinori Ohsumi

    Promotes it2016 Nobel laureate

    Worked out the core autophagy genes and mechanisms in yeast. His work is foundational cell biology, not a fasting endorsement.

  • Longevity & fasting influencers

    Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.

    Promotes itPodcasts, social media

    Frequently invoke "autophagy" to justify specific fasting windows and sell programs or supplements, often well beyond what human evidence supports.

  • Dr. Guido Kroemer

    Promotes itAutophagy researcher

    Leading academic on autophagy in aging and disease; emphasizes the science is real but complex, not a simple fasting dial.

Where the research comes from

Share of published research by country of origin.
PlaceShare of published research
USA34%
Japan30%
Europe22%
Other14%

Research published from: Japan, USA, Global.

How we got here

The term autophagy was introduced by the Belgian cell biologist Christian de Duve at the Ciba Foundation Symposium on Lysosomes in London in 1963, building on his discovery of the lysosome, which earned him a share of the 1974 Nobel Prize. A 1966 review by de Duve and Wattiaux already framed autophagy as piecemeal self-digestion under unfavorable food supply, linking it to starvation from the start. The field was transformed by the Japanese cell biologist Yoshinori Ohsumi, who used protease-deficient baker's yeast (Saccharomyces cerevisiae) in 1992 to make the process visible, then identified the core autophagy genes (the ATG family) across 1993 to 1996, work that won him the 2016 Nobel Prize in Physiology or Medicine. As fasting surged in popular culture from roughly 2016 onward, autophagy became its scientific banner, often detached from the careful and still-incomplete human evidence. The result is a real and profound piece of cell biology flattened into a marketing slogan with confident hour-by-hour claims the human science does not yet support.

  1. 1955Christian de Duve and colleagues describe the lysosome, the organelle later central to autophagy
  2. 1963de Duve coins the term autophagy at the Ciba Foundation Symposium on Lysosomes in London
  3. 1974de Duve shares the Nobel Prize for the structural and functional organization of the cell, including the lysosome
  4. 1992Ohsumi makes autophagy visible in protease-deficient baker's yeast, the first morphological evidence in yeast
  5. 1993Ohsumi's group reports isolation of autophagy-defective yeast mutants, opening the genetic dissection of the pathway
  6. 1996Ohsumi's lab identifies an early autophagy gene (APG5, now ATG5), seeding the ATG gene family
  7. 2016Ohsumi wins the Nobel Prize in Physiology or Medicine for the mechanisms of autophagy
  8. 2022A dedicated human study of the time course of fasting-induced autophagy (NCT04842864) is withdrawn after no participants could be enrolled
  9. 2025Bensalem et al. report in The Journal of Physiology an exploratory signal that intermittent time-restricted eating may raise autophagic flux in human blood cells at 6 months

At a glance

Means
"Self-eating" (Greek)
Nobel Prize
Ohsumi, 2016
Triggers
Fasting, exercise, energy stress
Human timing
Genuinely uncertain

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Autophagy. A short entry is not a safe entry.

  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.

Sources

  • Yoshinori Ohsumi, Nobel Prize in Physiology or Medicine 2016 (Facts)

    NobelPrize.org

    Primary studyConfidence: highChecked 2026-06-29

  • Yoshinori Ohsumi's Nobel Prize for mechanisms of autophagy: from basic yeast biology to therapeutic potential

    PubMed (28504774)

    secondaryConfidence: highChecked 2026-06-29

  • Autophagy wins the 2016 Nobel Prize in Physiology or Medicine (de Duve coined the term in 1963; Ohsumi's yeast ATG genes 1992 to 1996)

    PNAS via PubMed Central (PMC5240711)

    secondaryConfidence: highChecked 2026-06-29

  • Intermittent time-restricted eating may increase autophagic flux in humans: an exploratory analysis (Bensalem et al., 2025; LC3B-II flux in PBMCs; 6-month iTRE vs SC P=0.04, no within-group rise)

    The Journal of Physiology via PubMed (40345145)

    Primary studyConfidence: highChecked 2026-06-29

  • Intermittent fasting plus early time-restricted eating versus calorie restriction and standard care in adults at risk of type 2 diabetes (parent RCT of the autophagy reanalysis)

    Nature Medicine (2023)

    Primary studyConfidence: mediumChecked 2026-06-29

  • Time Course for Fasting-induced Autophagy in Humans (NCT04842864): 23-hour fast, LC3-II flux in adipose and PBMCs; status Withdrawn, 0 enrolled

    ClinicalTrials.gov

    Primary studyConfidence: highChecked 2026-06-29

  • Glycogen-Depleting Exercise Combined with Prolonged Fasting on Autophagy in Humans: A Randomised Controlled Crossover Trial (PROFASTA protocol; 3-day water fast; LC3B-II and p62 in PBMCs; no results yet)

    Nutrients via PubMed Central (PMC11677747)

    Primary studyConfidence: highChecked 2026-06-29

  • The effect of fasting or calorie restriction on autophagy induction: a review of the literature

    PubMed (30172870)

    secondaryConfidence: mediumChecked 2026-06-29

  • Autophagy: definition, process, fasting and signs (timing in humans uncertain; most disease studies are in animals)

    Cleveland Clinic

    secondaryConfidence: highChecked 2026-06-29

  • The Double-Edge Sword of Autophagy in Cancer: From Tumor Suppression to Pro-tumor Activity (context-dependent role; more is not uniformly better)

    PubMed Central (PMC7575731)

    secondaryConfidence: highChecked 2026-06-29

  • Christian de Duve (lysosome discovery; coined autophagy, endocytosis, exocytosis at 1963 Ciba symposium; 1974 Nobel)

    Wikipedia

    tertiaryConfidence: mediumChecked 2026-06-29